wsd albendazole cattle mini drench
wsd agribusiness pty ltd - albendazole - oral solution/suspension - albendazole carbamate-benzimidazole active 112.5 g/l - parasiticides - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - barber's pole worm - haemonchus placei | black scour worm - trichostrongylus spp. | hookworm - bunostomum phlebotomum | intestinal threadworm-strongyloides spp. | liver fluke | lungworm - dictyocaulus viviparus | nodule worm - oesophagostomum radiatum | small brown stomach worm - o. ostertagi | small intestinal worm - cooperia spp. | stomach hair worm | tapeworm - moniezia spp. | hair worm | including inhibited stages | intestinal hair worm | large lungworm | small hair worm | tapeworm - heads/segments
mebendazole tablet chewable
bryant ranch prepack - mebendazole (unii: 81g6i5v05i) (mebendazole - unii:81g6i5v05i) - mebendazole 100 mg
bendroflumethiazide 2.5mg tablets
de pharmaceuticals - bendroflumethiazide - oral tablet - 2.5mg
albendazole tablet, film coated
lineage therapeutics inc - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole is indicated for the treatment of the following infections: neurocysticercosis: albendazole is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, taenia solium . lesions considered responsive to albendazole therapy appear as nonenhancing cysts with no surrounding edema on contrast-enhanced computerized tomography. clinical studies in patients with lesions of this type demonstrate a 74% to 88% reduction in number of cysts; 40% to 70% of albendazole-treated patients showed resolution of all active cysts. hydatid disease: albendazole is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, echinococcus granulosus . this indication is based on combined clinical studies which demonstrated non-infectious cyst contents in approximately 80 to 90% of patients given albendazole for 3 cycles of therapy of 28 days each (see dosage and administration
benzicare mebendazole lamb and sheep drench
parafarm pty ltd - mebendazole - oral solution/suspension - mebendazole triazole active 50.0 g/l - parasiticides - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | hookworm - bunostomum trigonocephalum | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - dictyocaulus filaria | large mouthed bowel worm | nodule worm - o. columbianum | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tapeworm - moniezia spp. | thin necked intestinal worm | hair worm | intestinal hair worm | small hair worm | tapeworm - heads/segments | teladorsagia
pimobendan ep5 powder
letco medical, llc - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - pimobendan 1 g in 1 g
pimobendan powder
wisdom pharmaceutical co., ltd. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - pimobendan 1 kg in 1 kg
pimobendan powder
boehringer ingelheim espana, sa - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - pimobendan 1 mg in 100 l
bendamustine hydrochloride- bendamustine hydrochloride injection
eagle pharmaceuticals, inc - bendamustine hydrochloride (unii: 981y8sx18m) (bendamustine - unii:9266d9p3pq) - bendamustine hydrochloride injection is indicated for the treatment of patients with chronic lymphocytic leukemia. efficacy relative to first line therapies other than chlorambucil has not been established. bendamustine hydrochloride injection is indicated for the treatment of patients with indolent b-cell non-hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. bendamustine hydrochloride injection is contraindicated in patients with a known hypersensitivity (e.g., anaphylactic and anaphylactoid reactions) to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol. [see warnings and precautions (5.3)] pregnancy category d [see warnings and precautions (5.9)] risk summary bendamustine hydrochloride can cause fetal harm when administered to a pregnant woman. bendamustine caused malformations in animals, when a single dose was administered to pregnant animals. advise women to avoid becoming pregnant while receiving be
eskazole
glaxo smith kline (israel) ltd - albendazole - tablets - albendazole 400 mg - albendazole - albendazole - albendazole is indicated for the treatment of the following systemic helminth diseases: * echinococcosis (hydatid disease)albendazole is indicated for the treatment of liver, lung and peritoneal cysts. experience with bone cysts and those in the central nervous system and heart is limited. * cystic echinococcosis (caused by echinococcus granulosus)albendazole is used in patients with cystic echinococcosis:1. when surgical intervention is not feasible .2. as a co-adjunct to surgical treatment. 3. prior to surgical intervention. 4. if preoperative treatment was too short, if spillage has occurred or if viable cysts were found at surgery. 5. following percutaneous drainage of cysts for diagnostic or therapeutic reasons. * alveolar echinococcosis (caused by echinococcus multilocularis)although its efficacy has not been completely demonstrated in clinical trials, albendazole is used in patients with alveolar echinococcosis in the following situations:1. in inoperable disease, particularly in cases of local or distant metastasis.2. following palliative surgery.3. following radical surgery or liver transplantation.